Gazi University Dspace
Not a member yet
26981 research outputs found
Sort by
Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Five insights from the Global Burden of Disease Study 2019
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD)
2019 provides a rules-based synthesis of the available evidence on
levels and trends in health outcomes, a diverse set of risk factors, and
health system responses. GBD 2019 covered 204 countries and territories,
as well as first administrative level disaggregations for 22 countries,
from 1990 to 2019. Because GBD is highly standardised and comprehensive,
spanning both fatal and non-fatal outcomes, and uses a mutually
exclusive and collectively exhaustive list of hierarchical disease and
injury causes, the study provides a powerful basis for detailed and
broad insights on global health trends and emerging challenges. GBD 2019
incorporates data from 281 586 sources and provides more than 3.5
billion estimates of health outcome and health system measures of
interest for global, national, and subnational policy dialogue. All GBD
estimates are publicly available and adhere to the Guidelines on
Accurate and Transparent Health Estimate Reporting. From this vast
amount of information, five key insights that are important for health,
social, and economic development strategies have been distilled. These
insights are subject to the many limitations outlined in each of the
component GBD capstone papers